share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

SEC announcement ·  Jun 4 06:36
Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on May 30, 2024. The transaction was carried out on the open market with the shares sold at a price of $8.775 each, resulting in a total market value of $26,325. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 per share. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on May 30, 2024. The transaction was carried out on the open market with the shares sold at a price of $8.775 each, resulting in a total market value of $26,325. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 per share. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.